DNMT3A and myeloproliferative disorder: Loss of DNMT3A function using CRISPR models in JAK2V617F positive models of MPN induces a myelofibrosis phenotype with reduced erythropoiesis, progressive depletion of HSCs and accumulation of MPPs.